Drug Use in Prisoners
Epidemiology, Implications, and Policy Responses
Herausgeber: Kinner; Rich, Josiah D Jody
Schade – dieser Artikel ist leider ausverkauft. Sobald wir wissen, ob und wann der Artikel wieder verfügbar ist, informieren wir Sie an dieser Stelle.
Drug Use in Prisoners
Epidemiology, Implications, and Policy Responses
Herausgeber: Kinner; Rich, Josiah D Jody
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This edited volume provides the first ever comprehensive, international and multi-disciplinary review of the evidence regarding substance use and harms in people who cycle through prisons and jails. Grounded in solid evidence and a human rights framework, the book provides a roadmap for evidence-based reform.
This edited volume provides the first ever comprehensive, international and multi-disciplinary review of the evidence regarding substance use and harms in people who cycle through prisons and jails. Grounded in solid evidence and a human rights framework, the book provides a roadmap for evidence-based reform.
Produktdetails
- Produktdetails
- Verlag: Oxford University Press, USA
- Seitenzahl: 304
- Erscheinungstermin: 6. Februar 2018
- Englisch
- Abmessung: 233mm x 154mm x 20mm
- Gewicht: 426g
- ISBN-13: 9780199374847
- ISBN-10: 0199374848
- Artikelnr.: 48853775
- Verlag: Oxford University Press, USA
- Seitenzahl: 304
- Erscheinungstermin: 6. Februar 2018
- Englisch
- Abmessung: 233mm x 154mm x 20mm
- Gewicht: 426g
- ISBN-13: 9780199374847
- ISBN-10: 0199374848
- Artikelnr.: 48853775
Stuart Kinner has a PhD in forensic psychology and leads a program of research on the health of people who cycle through the criminal justice system. He is Professor of Adolescent and Young Adult Health Equity at the Murdoch Childrens Research Institute in Melbourne, Australia, and Honorary Professor at the University of Melbourne, and Griffith University. Stuart also Chairs Australia's National Youth Justice Health Advisory Group, and co-Chairs the Research Committee in the US-based Academic Consortium in Criminal Justice Health.
* Prologue
* Acknowledgments
* About the Editors
* Contributors
* Chapter 1: The 'drugs-crime nexus'
* Dominique de Andrade
* Chapter 2: The global epidemiology of drug use in prison
* Chloe Carpentier, Luis Royuela, Linda Montanari, Philip Davis
* Chapter 3: Injecting while incarcerated
* M-J Milloy
* Chapter 4: Alcohol use among incarcerated individuals
* David Wyatt Seal, Sarah Yancey, Manasa Reddy, Stuart A. Kinner
* Chapter 5: Tobacco use among prisoners
* Jennifer Clarke, Manasa Reddy
* Chapter 6: Substance use after release from prison
* Sarah Larney, Mark Stoové, Stuart A. Kinner
* Chapter 7: Drug use, HIV, and the high risk environment of prisons
* Lyuba Azbel, Frederick L. Altice
* Chapter 8: The perfect storm: Tuberculosis, substance use disorders
and incarceration
* Haider A. Al-Darraji, Frederick L. Altice
* Chapter 9: Drug use in prisoners and hepatitis
* Rebecca J. Winter, Margaret E. Hellard
* Chapter 10: Drug use in prison and mental health
* Kate Dolan, Michael Farrell, and Sahar Saeedi Moghaddam
* Chapter 11: Understanding the Risk Environment Surrounding Drug Use
in Prisons: The Unique Contributions of Qualitative Research
* Will Small, Ryan McNeil
* Chapter 12: Drug use and prison: The challenge of making human rights
protections a reality
* Joanne Csete, Rick Lines, Ralf Jürgens
* Chapter 13: Recidivism: The impact of substance abuse on continued
involvement in the justice system
* Faye Taxman, Mary Mun
* Chapter 14: Substance use and consequences among people who have been
incarcerated: A public health issue
* Ingrid Binswanger, Andrea K. Finlay
* Chapter 15: Supply reduction in prison: the evidence
* Robert L. Trestman, Ashbel T. Wall
* Chapter 16: Drug treatment for prisoners: Opioid substitution
treatment, therapeutic communities and cognitive behavioral therapy
* Kate Dolan, Zahra Alam-Mehrjerdi, Babak Moazen
* Chapter 17: Harm reduction in prisons
* Kathryn Snow, Michael Levy
* Chapter 18: Preventing drug-related death in recently released
prisoners
* Julie Brummer, Lars Møller, Stefan Enggist
* Chapter 19: Drug use in prisoners: Epidemiology, implications, and
policy responses
* Stuart A. Kinner, Josiah D. Rich
* Acknowledgments
* About the Editors
* Contributors
* Chapter 1: The 'drugs-crime nexus'
* Dominique de Andrade
* Chapter 2: The global epidemiology of drug use in prison
* Chloe Carpentier, Luis Royuela, Linda Montanari, Philip Davis
* Chapter 3: Injecting while incarcerated
* M-J Milloy
* Chapter 4: Alcohol use among incarcerated individuals
* David Wyatt Seal, Sarah Yancey, Manasa Reddy, Stuart A. Kinner
* Chapter 5: Tobacco use among prisoners
* Jennifer Clarke, Manasa Reddy
* Chapter 6: Substance use after release from prison
* Sarah Larney, Mark Stoové, Stuart A. Kinner
* Chapter 7: Drug use, HIV, and the high risk environment of prisons
* Lyuba Azbel, Frederick L. Altice
* Chapter 8: The perfect storm: Tuberculosis, substance use disorders
and incarceration
* Haider A. Al-Darraji, Frederick L. Altice
* Chapter 9: Drug use in prisoners and hepatitis
* Rebecca J. Winter, Margaret E. Hellard
* Chapter 10: Drug use in prison and mental health
* Kate Dolan, Michael Farrell, and Sahar Saeedi Moghaddam
* Chapter 11: Understanding the Risk Environment Surrounding Drug Use
in Prisons: The Unique Contributions of Qualitative Research
* Will Small, Ryan McNeil
* Chapter 12: Drug use and prison: The challenge of making human rights
protections a reality
* Joanne Csete, Rick Lines, Ralf Jürgens
* Chapter 13: Recidivism: The impact of substance abuse on continued
involvement in the justice system
* Faye Taxman, Mary Mun
* Chapter 14: Substance use and consequences among people who have been
incarcerated: A public health issue
* Ingrid Binswanger, Andrea K. Finlay
* Chapter 15: Supply reduction in prison: the evidence
* Robert L. Trestman, Ashbel T. Wall
* Chapter 16: Drug treatment for prisoners: Opioid substitution
treatment, therapeutic communities and cognitive behavioral therapy
* Kate Dolan, Zahra Alam-Mehrjerdi, Babak Moazen
* Chapter 17: Harm reduction in prisons
* Kathryn Snow, Michael Levy
* Chapter 18: Preventing drug-related death in recently released
prisoners
* Julie Brummer, Lars Møller, Stefan Enggist
* Chapter 19: Drug use in prisoners: Epidemiology, implications, and
policy responses
* Stuart A. Kinner, Josiah D. Rich
* Prologue
* Acknowledgments
* About the Editors
* Contributors
* Chapter 1: The 'drugs-crime nexus'
* Dominique de Andrade
* Chapter 2: The global epidemiology of drug use in prison
* Chloe Carpentier, Luis Royuela, Linda Montanari, Philip Davis
* Chapter 3: Injecting while incarcerated
* M-J Milloy
* Chapter 4: Alcohol use among incarcerated individuals
* David Wyatt Seal, Sarah Yancey, Manasa Reddy, Stuart A. Kinner
* Chapter 5: Tobacco use among prisoners
* Jennifer Clarke, Manasa Reddy
* Chapter 6: Substance use after release from prison
* Sarah Larney, Mark Stoové, Stuart A. Kinner
* Chapter 7: Drug use, HIV, and the high risk environment of prisons
* Lyuba Azbel, Frederick L. Altice
* Chapter 8: The perfect storm: Tuberculosis, substance use disorders
and incarceration
* Haider A. Al-Darraji, Frederick L. Altice
* Chapter 9: Drug use in prisoners and hepatitis
* Rebecca J. Winter, Margaret E. Hellard
* Chapter 10: Drug use in prison and mental health
* Kate Dolan, Michael Farrell, and Sahar Saeedi Moghaddam
* Chapter 11: Understanding the Risk Environment Surrounding Drug Use
in Prisons: The Unique Contributions of Qualitative Research
* Will Small, Ryan McNeil
* Chapter 12: Drug use and prison: The challenge of making human rights
protections a reality
* Joanne Csete, Rick Lines, Ralf Jürgens
* Chapter 13: Recidivism: The impact of substance abuse on continued
involvement in the justice system
* Faye Taxman, Mary Mun
* Chapter 14: Substance use and consequences among people who have been
incarcerated: A public health issue
* Ingrid Binswanger, Andrea K. Finlay
* Chapter 15: Supply reduction in prison: the evidence
* Robert L. Trestman, Ashbel T. Wall
* Chapter 16: Drug treatment for prisoners: Opioid substitution
treatment, therapeutic communities and cognitive behavioral therapy
* Kate Dolan, Zahra Alam-Mehrjerdi, Babak Moazen
* Chapter 17: Harm reduction in prisons
* Kathryn Snow, Michael Levy
* Chapter 18: Preventing drug-related death in recently released
prisoners
* Julie Brummer, Lars Møller, Stefan Enggist
* Chapter 19: Drug use in prisoners: Epidemiology, implications, and
policy responses
* Stuart A. Kinner, Josiah D. Rich
* Acknowledgments
* About the Editors
* Contributors
* Chapter 1: The 'drugs-crime nexus'
* Dominique de Andrade
* Chapter 2: The global epidemiology of drug use in prison
* Chloe Carpentier, Luis Royuela, Linda Montanari, Philip Davis
* Chapter 3: Injecting while incarcerated
* M-J Milloy
* Chapter 4: Alcohol use among incarcerated individuals
* David Wyatt Seal, Sarah Yancey, Manasa Reddy, Stuart A. Kinner
* Chapter 5: Tobacco use among prisoners
* Jennifer Clarke, Manasa Reddy
* Chapter 6: Substance use after release from prison
* Sarah Larney, Mark Stoové, Stuart A. Kinner
* Chapter 7: Drug use, HIV, and the high risk environment of prisons
* Lyuba Azbel, Frederick L. Altice
* Chapter 8: The perfect storm: Tuberculosis, substance use disorders
and incarceration
* Haider A. Al-Darraji, Frederick L. Altice
* Chapter 9: Drug use in prisoners and hepatitis
* Rebecca J. Winter, Margaret E. Hellard
* Chapter 10: Drug use in prison and mental health
* Kate Dolan, Michael Farrell, and Sahar Saeedi Moghaddam
* Chapter 11: Understanding the Risk Environment Surrounding Drug Use
in Prisons: The Unique Contributions of Qualitative Research
* Will Small, Ryan McNeil
* Chapter 12: Drug use and prison: The challenge of making human rights
protections a reality
* Joanne Csete, Rick Lines, Ralf Jürgens
* Chapter 13: Recidivism: The impact of substance abuse on continued
involvement in the justice system
* Faye Taxman, Mary Mun
* Chapter 14: Substance use and consequences among people who have been
incarcerated: A public health issue
* Ingrid Binswanger, Andrea K. Finlay
* Chapter 15: Supply reduction in prison: the evidence
* Robert L. Trestman, Ashbel T. Wall
* Chapter 16: Drug treatment for prisoners: Opioid substitution
treatment, therapeutic communities and cognitive behavioral therapy
* Kate Dolan, Zahra Alam-Mehrjerdi, Babak Moazen
* Chapter 17: Harm reduction in prisons
* Kathryn Snow, Michael Levy
* Chapter 18: Preventing drug-related death in recently released
prisoners
* Julie Brummer, Lars Møller, Stefan Enggist
* Chapter 19: Drug use in prisoners: Epidemiology, implications, and
policy responses
* Stuart A. Kinner, Josiah D. Rich